Association of vitamin D deficiency with diabetic gastroparesis and its intramuscular vitamin D treatment

https://doi.org/10.53730/ijhs.v6nS8.13799

Authors

  • Kanhiya Lal Talreja Medical unit, Dr Ruth K M Pfau Civil Hospital Karachi
  • Haseeb Ahmed Bhatti Dr. Ruth K M Pfau Civil Hospital Karachi
  • Humaira Siddiqui Dr. Ruth K M Pfau Civil Hospital Karachi
  • Saweeta Kumari Dr. Ruth K.M pafu civil Hospital Karachi
  • Rakesh Panjwani Senior Registrar in Medicine Department, Dow University Hospital Karachi
  • Maryam Mesud Department of General Medicine, Northwest General Hospital and Research Center
  • Muhammad Farhan Siddiq Rao Institute of Molecular Biology and Biotechnology (IMBB) Bahauddin Zakariya University Multan
  • Sudhair Abbas Bangash Faculty of Life Science, Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
  • Maryam Batool Department of Life Sciences, School of Science, University of Management and Technology, Lahore, Pakistan

Keywords:

malnourishment, vitamin D deficiency, diabetic gastroparesis, vitamin D treatment

Abstract

Introduction: Diabetic gastroparesis (DGp) is a component of autonomic neuropathy resulting from long-standing poorly controlled type 1 and type 2 diabetes. There are currently no approved vitamin D supplementation recommendations for people with DGp. Objectives: To investigate the relationship between vitamin D insufficiency and DGp, as well as the efficacy of intramuscular vitamin D therapy. Methodology: 71 patients (18 DM Gp & 53 Non-DM Gp) seeking treatment for gastroparesis symptoms were studied. The blood levels of vitamin D, homocysteine, gastric emptying test (GET) at 1, 2, and 4 h were recorded. 25-OH vitamin D levels were detected by kit. Potential clinical and statistical correlations between all results, symptoms, and GET data were explored. Descriptive statistics were used to investigate etiologic differences at baseline while multiple linear regression models were employed to explore relationships of vitamin D deficiency with diabetic gastroparesis and its intramuscular vitamin D treatment. Results: Majority of DGp patients were older than 18 years (88%) and were non-smokers (83%). The majority of those with and without diabetes were married (11; 71% vs. 34; 64%). The majority of participants in the DM group had only completed elementary school (n=7/18; 38.8%). 

Downloads

Download data is not yet available.

References

Bernstein C, Leslie W. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol, 2003;15: 857-864.

Blanton D, Han Z, Bierschenk L, Linga-Reddy MV, Wang H, Clare-Salzler M, Haller M, Schatz D, Myhr C, She JX, Wasserfall C, Atkinson M. Reduced serum vit-D-binding protein levels are associated with type 1 diabetes. Diabetes. 2011; 60:2566–2570.

Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of Gp. Am J Gastroenterol 2013;108:18-37.

Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of Gp in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol 2012;107:82-88.

Daram SR, Tang SJ, Abell TL. Video: temporary gastric electrical stimulation for Gp: endoscopic placement of electrodes (ENDOstim). Surg Endosc. 2011; 25:3444–3445.

Devaraj S, Jialal G, Cook T, Siegel D, Jialal I. Low vit-D levels in Northern American adults with the metabolic syndrome. Horm Metab Res. 2011; 43:72–74.

Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vit-D status of obesity. Obesity (Silver Spring). 2012; 20:1444–1448.

Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvit-D concentrations: considerations and implications. Int J Obes (Lond). 2012; 36:387–396

Grover, M., Farrugia, G., Stanghellini, V. (2019). Gp: A turning point in understanding and treatment. Gut 68(12): 2238–2250. doi:10.1136/gutjnl-2019-318712.

Hastie, TJ.; Tibshirani, RJ. Smoothing. In: Cox, DR.; Hinkley, DV.; Rubin, D.; Silverman, BW., editors. Generalized Additive Models. New York: Chapman and Hall; 1990. p. 9-38.

Kaline K, Bornstein SR, Bergmann A, Hauner H, Schwarz PE. The importance and effect of dietary fiber in diabetes prevention with particular consideration of whole grain products. Horm Metab Res. 2007; 39:687–693.

Karam C, Scelsa SN. Can vit-D delay the progression of ALS? Med Hypotheses. 2011; 76:643–645. [PubMed: 21310542]

Kedar A, Vedanarayanan V, Subramony C, Lahr CJ, Sunesara I, Griswold ME, Marshall GD, Abell TL. Quantification of Inflammation in the Enteric Plexus: Differences in Patients With Gp Who Have Acute vs. Non-Acute Symptom Onset. Gastroenterology. 2011:Sa2032.373.

Kedar, A., Nikitina, Y., Henry, O.R., K. B. Abell1, V. Vedanarayanan2, M. E. Griswold4, C. Subramony3, and T. L. Abell1. Gastric Dysmotility and Low Serum Vit-D Levels in Patients with Gp. Horm Metab Res . 2013 January ; 45(1): 47–53. doi:10.1055/s-0032-1323689.

Kedar1, Y. Nikitina1, O. R. Henry1, K. B. Abell1, V. Vedanarayanan2, M. E. Griswold4, C. Subramony3, and T. L. Abell. 2013. Gastric Dysmotility and Low Serum Vit-D Levels in Patients with Gp. Horm Metab Res . 2013 January ; 45(1): 47–53. doi:10.1055/s-0032-1323689

Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, Rissanen H, Montonen J, Reunanen A. Serum vit-D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008; 19:666–671. [PubMed: 18496468]

Krishnasamy, S., and Abell, T.L. 2018. DGp: Principles and Current Trends in Management. Diabetes Ther (2018) 9 (Suppl 1):S1–S42 https://doi.org/10.1007/s13300-018-0454-9

Mason RS. Vit-D: a hormone for all seasons. Climacteric. 2011; 14:197–203. [PubMed: 20964549]

McCray S. Lactose Intolerance: Considerations for the Clinician. Pract Gastroenterol, 2003:29; 21-39.

Meyer J. Chronic Morbidity after Ulcer Surgery. In: Sleisenger & Fordtran, (Ed.). Gastrointestinal Diseases 5th Ed, Saunders, Philadelphia, PA 1994:731-744.

Olausson EA, Storsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with DGp: a randomized controlled trial. Am J Gastroenterol 2014;109:375–85.

Parkman HP, Yates KP, Hasler WL, et al. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic Gp. Gastroenterology 2011;141:486–98, 98 e1-7.

Parkman HP, Yates KP, Hasler WL, Nguyan L, Pasricha PJ, Snape WJ, Farrugia G, Calles J, Koch KL, Abell TL, McCallum RW, Petito D, Parrish CR, Duffy F, Lee L, Unalp-Arida A, Tonascia J, Hamilton F. NIDDK Gp Clinical Research Consortium. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic Gp. Gastroenterology. 2011; 141:486– 498.

Parrish and Yoshida, 2005. Nutrition Intervention for the Patient with Gp: An Update. PRACTICAL GASTROENTEROLOGY.

Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vit-D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees (N) population. Horm Metab Res. 2009; 41:402–407.

Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd. Prevalence of hidden Gp in the community: the Gp “iceberg”. J Neurogastroenterol Motil 2012;18:34-42.

Published

27-12-2022

How to Cite

Talreja, K. L., Bhatti, H. A., Siddiqui, H., Kumari, S., Panjwani, R., Mesud, M., Rao, M. F. S., Bangash, S. A., & Batool, M. (2022). Association of vitamin D deficiency with diabetic gastroparesis and its intramuscular vitamin D treatment. International Journal of Health Sciences, 6(S8), 6394–6404. https://doi.org/10.53730/ijhs.v6nS8.13799

Issue

Section

Peer Review Articles

Most read articles by the same author(s)